# Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks

> **NCT01436279** · PHASE3 · COMPLETED · sponsor: **Boston University** · enrollment: 50 (actual)

## Conditions studied

- Cervical Preparation

## Interventions

- **DRUG:** Mifepristone
- **DEVICE:** osmotic dilators

## Key facts

- **NCT ID:** NCT01436279
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436279, "Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01436279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*